Cardiac Rhythm Management Devices Market to Rise at 7.0% CAGR During Forecast Year 2028 | Abbott, Abiomed, Biotronik SE & Co KG, Boston Scientific Corporation, Koninklijke Philips NV, MicroPort CRM, Zoll Medical Corporation

The Global Cardiac Rhythm Management Devices Market is projected to reach USD 41.67 billion by 2028, at a CAGR of 7.0% during a forecast period.

Cardiac rhythm management devices include pacemaker, cardiac resynchronization therapy, implantable cardioverter defibrillators and loop recorders heart failure. These devices perform various type of functions such as; bradycardia pacing for tachyarrhythmia. Nowadays there is an increase in the number of heart and cardiac disorders due to the sedentary lifestyle among the population and increase.

Get Sample Copy of This Report @ https://www.quincemarketinsights.com/request-sample-10266?utm_source=Openpr/SK

According to the World Health Organization (WHO), globally, cardiovascular diseases account for more than 30% of the total deaths. Nearly 33.5 million individuals worldwide also suffer from atrial fibrillation (AFib), the most prevalent type of severe arrhythmia. With the rise in the aging population in the US and Europe, the number of patients suffering from heart rhythm disorders is likely to grow. However, therapeutic radiation used in cancer treatment can influence the operation of a patient with implantable cardiac rhythm devices.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
1. Abbott
2. Abiomed
3. Biotronik SE & Co KG
4. Boston Scientific Corporation
5. Koninklijke Philips NV
6. MicroPort CRM
7. LivaNova Plc
8. Medtronic PPLC
9. Pacetronix
10. SchillerAG
11. Shenzhen Mindray Biomedical Electronics Co. Ltd
12. Zoll Medical Corporation

Key Factors Impacting Market Growth:
The increasing number of heart disorders across various age groups
Increasing demand from ambulatory care and home care
Rising expenditures of governments on the healthcare sector
The high cost of these devices with limited insurance coverage

Key Developments:
In February 2017, Abbott (US) announced the US Food and Drug Administration (FDA) approval of conditional labeling for magnetic resonance (MR) for both, the Assurity MRI pacemaker and the Tendril MRI pacing lead.
In January 2019, MicroPoort CRM (US) announced the first implants of its new pacemaker families, Eno(TM) and Teo(TM). The product features automatic MRI programming that is practical for patients and doctors, possibly reducing the expenses produced by workflows in hospitals.

The cardiac rhythm management devices market has been segmented into defibrillator, cardiac resynchronization therapy devices, and pacemakers. The defibrillator segment is expected to account for the largest market share during the forecast period. As per the American Heart Association (AHA), survival from cardiac arrest doubled when bystanders used a publicly-available automated external defibrillator (AED). Cardiac arrest victims who received a shock from a publicly-available AED had far more chances of survival and being discharged from the hospital than those who did not, accounting for 66.5% versus 43%, respectively. Therefore, it has been estimated that about 1,700 lives are saved in the US every year using a defibrillator. This indicates that the usage of defibrillators has experienced a significant rise, globally, over the recent years.

Make an Inquiry for purchasing this Report @ https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-10266?utm_source=Openpr/SK

This is mainly due to the developed of healthcare infrastructure, government initiatives, and rising incidence of arrhythmia demanding more cardiac implants. According to a report by the US CDC, more than 75,000 hospitalizations can be attributed to atrial fibrillation. Moreover, it is highlighted that a large part of the US population suffers from atrial fibrillation. Therefore, it is expected to rise further during the forecast period.

North America has held largest market share in Cardiac Rhythm Management Devices Market in 2018 and is anticipated to do so in forthcoming years also due to highly conducive factors such as favorable reimbursement schemes, sound infrastructure, high health awareness and copious expenditure in healthcare. Asia pacific is likely to witness a surge in cardiac rhythm management market revenue in forecast period owing to healthcare cover coming into realizable force in India and China. Furthermore, China has thrown open doors to an open economy and will shape the future of country's investment climate with multinational players holding landmark key positions.

Market Segmentation:
By Type:
Defibrillator
Cardiac Resynchronization Therapy Devices
Pacemakers
By End User:
Hospitals
Home Care
Ambulatory Care

By Region:
North America
By Country (US, Canada, Mexico)
By Type
By End User

Western Europe:
By Country (Germany, UK, France, Spain, Rest of Western Europe)
By Type
By End User

Eastern Europe:
By Country (Russia, Turkey, Rest of Eastern Europe)
By Type
By End User

Asia Pacific
By Country (China, Japan, India, Rest of Asia Pacific)
By Type
By End User

Middle East:
By Country (UAE, Qatar, Iran, Saudi Arabia, Rest of Middle East)
By Type
By End User

Rest of the World
By Region (Latin America, Brazil, Rest of the World)
By Type
By End User

Reasons to Buy This Report:

Market size estimation of the global cardiac rhythm management devices market on a regional and global basis
The unique research design for market size estimation and forecast
Profiling of major companies operating in the market with key developments
Broad scope to cover all the possible segments helping every stakeholder in the market

Contact:

Quince Market Insights
Ajay D. (Knowledge Partner)
Office No- A109,
Pune, Maharashtra 411028
Phone: IN +91 706 672 5858
US +1 208 405 2835
UK +44 121 364 6144
APAC +91 706 672 4848
Email: sales@quincemarketinsights.com
Web: www.quincemarketinsights.com

ABOUT US:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the world's most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

This release was published on openPR.